Good Riddance

SB 155 is dead.

A controversial bill to mandate vaccines against a sexually transmitted disease that causes cervical cancer won’t move forward this year, its sponsor said Thursday.

There was just too much sentiment against the bill, state Sen. Don Balfour said.

I still think someone should form a “Parents Against Don” group, but I’ll get back to liking him shortly.

8 comments

  1. Joy says:

    Yea! I wondered how long this would take, after hearing one of the developers of the vaccine say it was not designed for children, was not tested on children, and should not be used on children.

  2. grabbingsand says:

    … was not tested on children.

    Not so. And I would be interested in your source for this developer quote. As far as testing was concerned, children were included indeed in studies.

    From the FDA’s approval statement on Gardasil:

    Four studies, one in the United States and three multinational, were conducted in 21,000 women to show how well Gardasil worked in women between the ages of 16 and 26 by giving them either the vaccine or placebo. The results showed that in women who had not already been infected, Gardasil was nearly 100 percent effective in preventing precancerous cervical lesions, precancerous vaginal and vulvar lesions, and genital warts caused by infection with the HPV types against which the vaccine is directed. While the study period was not long enough for cervical cancer to develop, the prevention of these cervical precancerous lesions is believed highly likely to result in the prevention of those cancers.

    The studies also evaluated whether the vaccine can protect women already infected with some HPV types included in the vaccine from developing diseases related to those viruses. The results show that the vaccine is only effective when given prior to infection.

    Two studies were also performed to measure the immune response to the vaccine among younger females aged 9-15 years. Their immune response was as good as that found in 16-26 year olds, indicating that the vaccine should have similar effectiveness when used in the 9-15 year age group.

    More on the efficacy of HPV vaccine can be found at CDC.gov.

  3. jonlester says:

    We went over this pretty thoroughly at RedState recently. The idea of offering some protection always sounds better than denying any protection, of course, but other questions came up in the conversation. Aside from effectiveness and testing issues and the propriety of compulsory vaccination, we also wondered if the drug companies are now trying to recover their research and development costs directly from the taxpayers.

  4. Know Nothing says:

    Congrats! We helped kill a cancer immunization attempt. Next it’s on to the menigitis vaccine…

  5. Jeff Emanuel says:

    Because if government doesn’t mandate it, you can’t get it? Come on.

    It’s available to the public. They even have TV commercials advertising its availability.

Comments are closed.